Compliance with anticonvulsant therapy in a hospital clinic and in the community.

1 Seizure control, saliva anticonvulsant concentration, prescribing habits and compliance with anticonvulsant medication have been compared in 86 epileptic subjects attending either a specialist hospital clinic or general practice surgeries. 2 Of all subjects experiencing recurrent seizures 70% had saliva concentrations of phenytoin below the range equivalent to the 'therapeutic range' of plasma concentration. Mean saliva phenytoin concentrations did not differ significantly between the two treatment settings and were low largely because of the low mean dosage prescribed. 3 Eleven subjects in all had no detectable phenytoin in their and could clearly be identified as noncompliant. Freedom from seizures appeared to predispose to poor compliance in these subjects as well as among those admitting repeated omission of doses.

[1]  F. Buchthal,et al.  Clinical and electroencephalographic correlations with serum levels of diphenylhydanotin. , 1960, Archives of neurology.

[2]  J. Haynes,et al.  Some causes of ineffectiveness of diphenylhydantoin. , 1966, Archives of neurology.

[3]  J. MacGee Rapid determination of diphenylhydantoin in blood plasma by gas-liquid chromatography. , 1970, Analytical chemistry.

[4]  A. Handley,et al.  Supervision of Epileptic Patients Taking Phenytoin , 1970, British medical journal.

[5]  M. Eadie,et al.  Plasma diphenylhydantoin levels in Australian adults. , 1974, Australian and New Zealand journal of medicine.

[6]  J. M. Sutherland,et al.  Diphenylhydantoin concentrations in saliva. , 1974, Archives of neurology.

[7]  F. Williams,et al.  Human brain, cerebrospinal fluid, and plasma concentrations of diphenylhydantoin and phenobarbital , 1974, Clinical pharmacology and therapeutics.

[8]  L. O'Tuama,et al.  Phenytoin and phenobarbital concentrations in saliva and plasma measured by radioimmunoassay , 1975, Clinical pharmacology and therapeutics.

[9]  E. Critchley,et al.  Control of epilepsy with a single daily dose of phenytoin sodium. , 1975, British journal of clinical pharmacology.

[10]  E. Reynolds,et al.  ONE DRUG (PHENYTOIN) IN THE TREATMENT OF EPILEPSY , 1976, The Lancet.

[11]  G. Scambler,et al.  HOW DOCTORS DEAL WITH EPILEPSY , 1977, The Lancet.

[12]  C. Dollery,et al.  Drug concentration in saliva , 1978, Clinical pharmacology and therapeutics.